Singapore markets closed

Straits Times Index
3,265.95
+1.42(+0.04%)
S&P 500
5,187.67
-0.03(-0.00%)
Dow
39,056.39
+172.13(+0.44%)
Nasdaq
16,302.76
-29.80(-0.18%)
Bitcoin USD
61,196.95
-1,098.25(-1.76%)
CMC Crypto 200
1,320.33
+20.23(+1.56%)

LLY Mar 2025 790.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

73.49

0.00

(0.00%)

As of 03:50PM EDT. Market open.

Thomson Reuters StreetEvents
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
Zacks
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Benzinga
What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
Tuesday, the FDA said it would convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee on Monday, June 10, 2024, to discuss Eli Lilly and Co’s (NYSE:LLY) donanemab for early symptomatic Alzheimer’s disease. The open public hearing portion of the meeting will be conducted virtually. The Phase 3 study submitted as part of this application, TRAILBLAZER-ALZ 2, is a double-blind, placebo-controlled study to evaluate the safety and efficacy of donanemab in pa